Skip to content

Certain protease inhibitors and abacavir linked to heart attacks in two large cohort studies

Two novel ‘enhancer’ drugs boost protease inhibitors as much as ritonavir

Switching from Kaletra to raltegravir improves lipid profiles at the risk of viral rebound

Interleukin-2 shows no benefit in two large clinical trials

Seminal HIV: cell-free virus, not infected cells, leads to transmission between men

Microbicide reduces HIV infections by 30% in first success for field

Test can predict non-Hodgkin's lymphoma in people with HIV

When to start HIV treatment: cohort studies disagree on how early

HIV sporadically detectable in semen of men with undetectable plasma viral loads